187 related articles for article (PubMed ID: 19696989)
1. Clinicopathological features and genotype distribution in patients with hepatitis C virus chronic liver disease.
Abraham R; Ramakrishna B; Balekuduru A; Daniel HD; Abraham P; Eapen CE; Kurian G
Indian J Gastroenterol; 2009; 28(2):53-8. PubMed ID: 19696989
[TBL] [Abstract][Full Text] [Related]
2. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.
Adinolfi LE; Utili R; Andreana A; Tripodi MF; Marracino M; Gambardella M; Giordano M; Ruggiero G
Dig Dis Sci; 2001 Aug; 46(8):1677-83. PubMed ID: 11508667
[TBL] [Abstract][Full Text] [Related]
3. Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.
Kara B; Gunesacar R; Doran F; Kara IO; Akkiz H
Adv Ther; 2007; 24(5):972-82. PubMed ID: 18029322
[TBL] [Abstract][Full Text] [Related]
4. Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients.
Adinolfi LE; Utili R; Andreana A; Tripodi MF; Rosario P; Mormone G; Ragone E; Pasquale G; Ruggiero G
Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):299-304. PubMed ID: 10750650
[TBL] [Abstract][Full Text] [Related]
5. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
[TBL] [Abstract][Full Text] [Related]
6. Histological features of chronic hepatitis C in haemodialysis patients.
Sakellariou S; Boletis JN; Sypsa V; Psichogiou M; Tiniakos D; Delladetsima I
Liver Int; 2014 Jul; 34(6):e56-61. PubMed ID: 25234282
[TBL] [Abstract][Full Text] [Related]
7. Predictors of histological activity and fibrosis in chronic Hepatitis C infection: a study from North India.
Singh S; Gupta R; Malhotra V; Sarin SK
Indian J Pathol Microbiol; 2010; 53(2):238-43. PubMed ID: 20551524
[TBL] [Abstract][Full Text] [Related]
8. Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases.
Rafi H; Kabbaj N; Salihoun M; Amrani L; Acharki M; Guedira M; Nya M; Amrani N
Arab J Gastroenterol; 2011 Sep; 12(3):136-8. PubMed ID: 22055591
[TBL] [Abstract][Full Text] [Related]
9. Improvement of steatosis after interferon therapy in HCV genotype 4 is related to weight loss.
Esmat G; El Akel W; Metwally M; Soliman A; Doss W; Hamid MA; Kamal M; Zalata K; Khattab H; El-Kassas M; Esmat M; Hasan A; El-Raziky M
Indian J Gastroenterol; 2009; 28(2):45-8. PubMed ID: 19696987
[TBL] [Abstract][Full Text] [Related]
10. Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort.
Ramcharran D; Wahed AS; Conjeevaram HS; Evans RW; Wang T; Belle SH; Yee LJ
J Viral Hepat; 2011 Apr; 18(4):e144-52. PubMed ID: 21070504
[TBL] [Abstract][Full Text] [Related]
11. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
[TBL] [Abstract][Full Text] [Related]
12. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
Patton HM; Patel K; Behling C; Bylund D; Blatt LM; Vallée M; Heaton S; Conrad A; Pockros PJ; McHutchison JG
J Hepatol; 2004 Mar; 40(3):484-90. PubMed ID: 15123364
[TBL] [Abstract][Full Text] [Related]
13. Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?
Sharma P; Balan V; Hernandez J; Rosati M; Williams J; Rodriguez-Luna H; Schwartz J; Harrison E; Anderson M; Byrne T; Vargas HE; Douglas DD; Rakela J
Dig Dis Sci; 2004 Jan; 49(1):25-9. PubMed ID: 14992430
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease.
Hissar SS; Goyal A; Kumar M; Pandey C; Suneetha PV; Sood A; Midha V; Sakhuja P; Malhotra V; Sarin SK
J Med Virol; 2006 Apr; 78(4):452-8. PubMed ID: 16482560
[TBL] [Abstract][Full Text] [Related]
15. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.
Liu CJ; Chen PJ; Jeng YM; Huang WL; Yang WS; Lai MY; Kao JH; Chen DS
J Hepatol; 2005 Aug; 43(2):235-42. PubMed ID: 15964656
[TBL] [Abstract][Full Text] [Related]
16. Incidentally detected asymptomatic hepatitis C virus infection with significant fibrosis: Possible impacts on management.
Gupta RK; Sakhuja P; Majumdar K; Ali S; Srivastava S; Sachdeva S; Sharma BC; Puri AS
Indian J Pathol Microbiol; 2018; 61(3):345-349. PubMed ID: 30004052
[TBL] [Abstract][Full Text] [Related]
17. TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.
Sagnelli C; Merli M; Uberti-Foppa C; Hasson H; Grandone A; Cirillo G; Salpietro S; Minichini C; Starace M; Messina E; Morelli P; Miraglia Del Giudice E; Lazzarin A; Coppola N; Sagnelli E
World J Gastroenterol; 2016 Oct; 22(38):8509-8518. PubMed ID: 27784963
[TBL] [Abstract][Full Text] [Related]
18. [Steatosis and non-alcoholic steatohepatitis in patients with chronic hepatitis due to hepatitis C virus infection].
Coral G; de Mattos AA; de Mattos AZ; dos Santos DE
Arq Gastroenterol; 2006; 43(4):265-8. PubMed ID: 17406752
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus infection and liver steatosis.
Ramalho F
Antiviral Res; 2003 Oct; 60(2):125-7. PubMed ID: 14638408
[TBL] [Abstract][Full Text] [Related]
20. Steatosis and chronic hepatitis C virus infection.
Khokhar N; Mushtaq M; Mukhtar AS; Ilahi F
J Pak Med Assoc; 2004 Mar; 54(3):110-2. PubMed ID: 15129866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
